Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KLINISK TANDTEKNIKER PERNILLE ASMUSSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7%   Bankruptcy risk   6.4% 5.4% 4.1% 3.8% 3.4% 2.3% 13.7% 11.7%   Credit score (0-100)   39 43 50 51 52 64 2 2   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   29.7 49.2 46.6 94.1 -9.3 -17.3 0.0 0.0   EBITDA   29.7 49.2 46.6 94.1 -9.3 -17.3 0.0 0.0   EBIT   29.7 49.2 46.6 94.1 -9.3 -17.3 0.0 0.0   Pre-tax profit (PTP)   46.9 182.3 171.7 295.5 92.8 379.9 0.0 0.0   Net earnings   46.9 182.3 171.7 295.5 92.8 379.9 0.0 0.0   Pre-tax profit without non-rec. items   46.9 182 172 295 92.8 380 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   16.9 199 371 558 651 918 679 679   Interest-bearing liabilities   364 179 7.0 57.6 62.1 8.5 0.0 0.0   Balance sheet total (assets)   404 402 458 651 721 935 679 679   Net Debt   364 179 -49.5 57.6 -9.3 -276 -679 -679     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   29.7 49.2 46.6 94.1 -9.3 -17.3 0.0 0.0   Gross profit growth   0.0% 65.6% -5.2% 102.0% 0.0% -87.0% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   404 402 458 651 721 935 679 679   Balance sheet change%   0.0% -0.6% 14.1% 42.1% 10.8% 29.6% -27.4% 0.0%   Added value   29.7 49.2 46.6 94.1 -9.3 -17.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.8% 49.4% 41.1% 53.3% 13.9% 46.2% 0.0% 0.0%   ROI %   22.1% 52.4% 46.7% 59.5% 14.3% 46.7% 0.0% 0.0%   ROE %   277.8% 168.7% 60.2% 63.6% 15.3% 48.4% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   4.2% 49.6% 81.0% 85.8% 90.3% 98.2% 100.0% 50.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   1,227.2% 365.0% -106.2% 61.2% 100.2% 1,592.1% 0.0% 0.0%   Gearing %   2,158.1% 90.1% 1.9% 10.3% 9.5% 0.9% 0.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   20.5% 6.2% 5.3% 0.0% 4.2% 7.9% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   0.0 0.0 0.7 0.0 1.0 17.2 0.0 0.0   Current Ratio   0.0 0.0 0.7 0.0 1.0 17.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 56.5 0.0 71.4 284.6 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -383.1 -200.8 -29.1 -91.6 1.2 268.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0